Company: ARMP
Filing Date: 2025-08-12
Form Type: 8-K
Source: 0001558370-25-011227
Chunk: 1

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-12
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01

Financial Statements and Exhibits.

(d)Exhibits.

  Exhibit      Description                                                               
      No.                                                                                
     10.1      Credit and Security Agreement, dated August 11, 2025.                     
     99.1      Press Release, dated August 12, 2025.                                     
 ─────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: August 12, 2025      Armata Pharmaceuticals, Inc.                                          
 ───────────────────────────────────────────────────────────────────────────────────────────────────
                             By:                               /s/ David House                     
                             Name:                             David House                         
                             Title:                            Senior Vice President, Finance and